United Therapeutics (UTHR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access UTHR Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how United Therapeutics balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent1,279.70
Marketable Securities, Current SH874.00
Cash & Short-term Investments2,153.00
Accounts receivable312.00
Inventories178.30
Other Current Assets228.00
Total Current Assets2,872.00
Equipment/Property/Plant Net1,840.70
Intangible Assets115.50
Long-term investments1,317.40
Other Assets, Noncurrent568.60
Total Assets6,714.20
Liabilities
Accounts Payable and Accrued Liabilities, Current LI498.30
Line of Credit, Current LO0.00
Other Liabilities, Current100.80
Total Current Liabilities599.10
Total Long-term Debt0.00
Other liabilities, Noncurrent214.00
Total Liabilities813.10
Stockholders' Equity
Treasury Stock Common Value-5,441.60
Common Stock Value0.80
Additional Paid In Capital Common Stock2,520.30
Retained Earnings / Accumulated Deficit8,831.80
Other Equity-10.20
Common Stockholder's Equity5,901.10
Total Stockholder's Equity5,901.10
Liabilities & Stockholder's Equity6,714.20
4 historic quarters locked

Sign in to unlock the full United Therapeutics balance sheet history.

About United Therapeutics Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001082554-26-000027

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.